Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $1.42 | Prev. Close $1.37 | Circuit Range N/A |
Day Range $1.42 - $1.42 | Year Range $0.97 - $7.89 | Volume 275 |
Average Traded $1.42 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $1.42 | $1.47 | +0.00% |
20-May-26 | $1.42 | $1.47 | +8.09% |
18-May-26 | $1.35 | $1.36 | -13.92% |
15-May-26 | $1.65 | $1.58 | -7.60% |
14-May-26 | $1.82 | $1.71 | -4.47% |
13-May-26 | $1.79 | $1.79 | -1.38% |
12-May-26 | $1.82 | $1.81 | -3.46% |